Cite
MLA Citation
Emily Durden et al.. “Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States.” Journal of medical economics, vol. 19, 2016, pp. 403–413. http://access.bl.uk/ark:/81055/vdc_100033993032.0x000041